Switch from Clindamycin to an Alternative Antibiotic for Infected Herpes Zoster
Stop clindamycin immediately and switch to either trimethoprim-sulfamethoxazole (TMP-SMX) or doxycycline for the bacterial superinfection of the zoster rash. Clindamycin-associated diarrhea raises concern for Clostridioides difficile infection (CDI), which occurs in up to 10-30% of clindamycin users and can be life-threatening if it progresses 1.
Immediate Actions
Discontinue clindamycin now - this is the single most important intervention, as continued use dramatically increases CDI risk and recurrence 2. The FDA label explicitly warns that clindamycin should be prescribed with caution in patients with gastrointestinal disease, particularly colitis, and that diarrhea is a common problem that can develop even 2+ months after the last dose 1.
Assess diarrhea severity to determine if this is simple antibiotic-associated diarrhea versus CDI:
- If mild diarrhea without fever, abdominal pain, or systemic symptoms: likely antibiotic effect, will resolve with drug discontinuation
- If moderate-severe diarrhea (≥3 unformed stools/24h), fever, abdominal cramping, or bloody stools: test for CDI with nucleic acid amplification test plus toxin assay 2
Alternative Antibiotic Selection
For the bacterial superinfection of herpes zoster, choose one of these oral alternatives:
First-Line Options (in order of preference):
Trimethoprim-sulfamethoxazole (TMP-SMX): One double-strength tablet (160/800 mg) twice daily 3, 4
- Excellent coverage for skin and soft tissue infections including MRSA
- Does NOT cause CDI
- Well-tolerated with minimal GI effects
Doxycycline: 100 mg twice daily 3, 4, 5
- Equally effective for SSTI
- Does NOT cause CDI
- Alternative if sulfa allergy present
Duration
Continue for 7-10 days total (counting from when clindamycin was started), individualized based on clinical response 3, 4.
Why These Alternatives Work
The IDSA guidelines for skin and soft tissue infections explicitly recommend TMP-SMX and tetracyclines (doxycycline) as equivalent alternatives to clindamycin for empirical coverage of community-acquired MRSA in outpatient SSTIs 3, 4. Both have strong evidence (A-II level) supporting their use. A 2018 consensus conference reaffirmed these as appropriate oral options for MRSA coverage 5.
Critical distinction: Unlike clindamycin, neither TMP-SMX nor doxycycline significantly disrupt the gut microbiome in ways that predispose to CDI. Clindamycin is one of the highest-risk antibiotics for CDI development 2, 1.
If Diarrhea Persists or Worsens
Test for CDI if diarrhea continues >24-48 hours after stopping clindamycin or if any of these develop:
- Fever
- Severe abdominal pain/cramping
- Bloody or mucoid stools
- Worsening symptoms despite stopping clindamycin
If CDI is confirmed, treat with:
- Vancomycin 125 mg orally 4 times daily for 10 days (preferred over metronidazole per 2018 IDSA/SHEA guidelines) 2
- OR Fidaxomicin 200 mg twice daily for 10 days (if available)
Common Pitfalls to Avoid
Do NOT restart clindamycin - even if diarrhea resolves, the risk of recurrent CDI remains elevated for months 1
Do NOT use antimotility agents (loperamide) if CDI is suspected - this can precipitate toxic megacolon 2
Do NOT delay switching antibiotics - every additional day on clindamycin increases CDI risk
Do NOT assume all diarrhea is CDI - simple antibiotic-associated diarrhea is more common and resolves with drug discontinuation alone
Ensure adequate antiviral coverage continues - the patient should remain on appropriate antiviral therapy (acyclovir, valacyclovir, or famciclovir) for the herpes zoster itself 6, 7
The combination of stopping the offending antibiotic and switching to a non-CDI-inducing alternative addresses both the immediate diarrhea concern and maintains appropriate coverage for the bacterial superinfection.